Showing results (691-700 of 892) with videos related to

Sort By:
Pageof 90
Healthcare (Amsterdam, Netherlands)|March 23, 2016
Short-term and long-term effectiveness of a post-hospital care transitions program in an older, medically complex populationPaul Y Takahashi, James M Naessens, Stephanie M Peterson, et al.
Molecular Pharmacology|July 3, 2009
Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessmentXi-Ping Huang, Vincent Setola, Prem N Yadav, et al.
Chemical Communications (Cambridge, England)|April 29, 2010
Liposome-mediated amplified detection of cell-secreted matrix metalloproteinase-9Jayati Banerjee, Andrea J Hanson, Erin K Nyren-Erickson, et al.
Archives of Internal Medicine|April 18, 2012
A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visitsPaul Y Takahashi, Jennifer L Pecina, Benjavan Upatising, et al.
Critical Care Nursing Quarterly|November 24, 2021
Development, Implementation, and Evaluation of an Early Mobility Protocol in a Regional Level II Trauma CenterCatherine A McCarty, Colleen M Renier, Pat G Conway, et al.
Global Change Biology|June 1, 2019
Experimental warming alters the community composition, diversity, and N2 fixation activity of peat moss (Sphagnum fallax) microbiomesAlyssa A Carrell, Max Kolton, Jennifer B Glass, et al.
Nurse Educator|January 29, 2015
Developing curriculum recommendations for environmental health in nursingJeanne M Leffers, Claudia M Smith, Ruth McDermott-Levy, et al.
ACS Nano|April 6, 2013
Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastomaBong-Seop Lee, Takayuki Amano, Hong Qiang Wang, et al.
Journal of Comparative Effectiveness Research|November 18, 2025
Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims databaseTimothy E Ritter, Christina J Hanson, Christopher Fernandes, et al.
Investigational New Drugs|April 25, 2020
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumorsMojun Zhu, Julian R Molina, Grace K Dy, et al.
Pageof 90